How many investments has Asahi Kasei Corporate Venture Capital made?

Asahi Kasei Corporate Venture Capital has 59 tracked investments, 1 of which have exited.

What stage does Asahi Kasei Corporate Venture Capital invest at?

Asahi Kasei Corporate Venture Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What is Asahi Kasei Corporate Venture Capital's typical check size?

Asahi Kasei Corporate Venture Capital typically writes checks of $200K – $5M.

What sectors does Asahi Kasei Corporate Venture Capital focus on?

Asahi Kasei Corporate Venture Capital focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Construction Tech, Digital Health, Energy, Hardware, Healthtech, IoT, Medical Devices, New Materials, PropTech, Robotics, Semiconductors.

Where is Asahi Kasei Corporate Venture Capital located?

Asahi Kasei Corporate Venture Capital is headquartered in Menlo Park, US.

Does Asahi Kasei Corporate Venture Capital lead rounds?

Yes, Asahi Kasei Corporate Venture Capital leads investment rounds.

Who does Asahi Kasei Corporate Venture Capital co-invest with?

Asahi Kasei Corporate Venture Capital most often shares deals with Vivo Capital, ATEL Ventures, Collaborative Fund, among 172 tracked co-investors.

Asahi Kasei Corporate Venture Capital

Corporate VC

Menlo Park · Pre-Seed–Late Stage · 25 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Asahi Kasei Corporate Venture Capital

Each arrow is one introduction. Sign up to fill in the first one.

1,545 people can intro you to Chris

Ask Colin Wang to introduce you to Chris Greeno

You →Colin · together at Bridgebio →Chris

429 people can intro you to Alex

Ask Jamie Chen to introduce you to Alex Dupée

You →Jamie · together at Alchemy Partners →Alex

274 people can intro you to Jeff

Ask Sam Okafor to introduce you to Jeff Chen

You →Sam · together at Kewazo →Jeff

Ian Cash40 people can intro you

Your email: who you already know at Asahi Kasei Corporate Venture Capital, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Asahi Kasei Corporate Venture Capital team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict

Investment thesis

Asahi Kasei Corporate Venture Capital was established in 2008 to create new long-term business opportunities for its parent company, Asahi Kasei. It invests in innovative global companies in areas of strategic relevance to the parent's core sectors of Materials, Homes, and Health Care. The team, spread across Menlo Park, the Boston area, Düsseldorf, and Shanghai, combines expertise in R&D, startup operations, and venture capital. The firm invests across all stages, with initial checks ranging from several hundred thousand dollars up to several million depending on the opportunity, and can lead investments in the right circumstances.

Source: firm website, verified Sep 27, 2026.

Leave your own feedback

Stage

Pre-Seed–Late Stage

Check

$200K – $5M

Menlo Park, MA, US

Leads rounds

Leads

Instruments

Equity

Founded

2008

Tracked investments

Acquisitions

Team · 25 people

from the firm's website & curated & public directories

Jeff Chen· Managing Director· Albany, NYin

Joined Asahi Kasei Corporate VC in 2023, having previously been VP of Product Management and Development at Crystal IS, a semiconductor device company acquired by Asahi Kasei in 2012. He holds a PhD in electrical engineering from Stony Brook University and an MBA from NYU Stern.

John· Investment Professional, Building Technology

Brings 30 years of experience identifying and commercializing technologies in the building ecosystem. Previously held leadership roles in building products and homebuilding, including R&D positions at major firms and service as director of MIT's Innovative Housing Technology Program. Founder of multiple building material companies and board member of Plant Prefab, Toolbx, and Skipp Technologies. Holds a master's degree in architecture, planning, and building technology from MIT.

Masatoshi· Investment Professional, Construction & Real Estate

Focuses on construction and real estate investment. Previously worked as a production engineer at JFE Steel and Asahi Kasei for 13 years. Holds a master's degree in mechanical engineering from Keio University.

Ian Cash· Managing Director, Asahi Kasei Ventures· London, England, United Kingdomin

Joined Alchemy in 2006 to establish the Special Opportunities business, which has raised GBP 3.1bn across five funds. Over 28 years in European distressed debt; previously co-founded Mizuho International's Global Special Situations Group.

Howard Kim· Managing Director· Boston

Managing Director focused on healthcare investments, joining Asahi Kasei America in 2016. He previously worked at Advent International and Hambrecht and Quist Capital Management, and served as CMO and VP of Business Development at a medical device company. He holds a BA from Harvard College and an MD from Tufts School of Medicine.

Masatoshi Sakuma· Principal· Menlo Park

Principal focusing on Construction & Real Estate. He worked as a production engineer at JFE Steel and Asahi Kasei for 13 years. He holds a master's degree in Mechanical Engineering from Keio University.

Alex Dupée· Investment Manager· London, England, United Kingdomin

Joined Alchemy in 2012 from Lloyds Banking Group; previously a strategy consultant at L.E.K. Consulting.

adupee@alchemypartners.co.uk

Chris Greeno· Investment Director· Bostonin

Joined the Asahi Kasei CVC team in 2020, focusing on medtech, digital therapeutics, and biotech. He previously worked in life sciences strategy consulting and biotech business development. He holds a BA in biology and economics from Williams College and an MBA in healthcare management from The Wharton School.

Yiqing Tao· Investment Director· Shanghaiin

Investment Director based in Shanghai in charge of all CVC China activities, including investment strategy, direct and VC fund investments, and business collaborations. She previously worked in venture capital and private equity in China. She holds an MSc in Finance from Cass Business School, London.

Daisuke Hotta· Manager· Menlo Parkin

Manager concentrating on Climate Tech, materials, and sustainability ventures. He spent five years in R&D on a membrane technology for the food and pharmaceutical industries and has filed over ten global patents. He holds a Master of Science in Macromolecular Science from Osaka University.

Hirotaka Asai· Manager· Düsseldorfin

Manager exploring new business opportunities with Asahi Kasei's mobility and industrial materials businesses. He spent six years in materials engineering R&D and two years in marketing and strategy. He holds a master's degree in Applied Life Science from Kyoto University.

John S. Crowley· Senior Advisor· Portland, Mainein

Senior Advisor with a 30-year career in building technologies and homebuilding, having held R&D and executive roles at NVR Ryan Homes, PHI Building Systems, and Rollease Acmeda. He directed the MIT Innovative Housing Technology Program and serves on the boards of Plant Prefab, Toolbx, and Skipp Technologies. He holds a master's degree in architecture, planning & building technology from MIT.

Ken Kitamura· Manager· Menlo Parkin

Joined Asahi Kasei Corporate VC in 2024, previously working as a senior innovation architect on new business creation projects in hydrogen, battery, and semiconductors at Asahi Kasei, and at Crystal IS. He holds a master's degree in chemistry from Hokkaido University and an MBA from NUCB business school.

Kohei Miyabe· Manager· Tokyoin

Manager in charge of healthcare investment with expertise in pharmaceutical development, formulation science, and CMC work. His research led to an approved pharmaceutical in Japan and over ten patents. He holds a master's degree in agricultural science from Nagoya University.

Masa Kaneta· Senior Manager· Tokyo

Senior Manager exploring new business opportunities in materials and sustainability. He worked in Asahi Kasei Corporate Strategy on business development, investment control, and carbon neutral projects, and held R&D and operations roles in Consumable business units for 18 years.

Michinori Muraoka· Manager· Düsseldorfin

Manager exploring new business opportunities in materials and sustainability. He worked in Asahi Kasei's membrane division and spent five years in India as country manager for membrane technology business development in the water sector. He holds a BBA from Hokkaido University and an MBA from Kobe University.

Naoki Isobe· Manager· Menlo Parkin

Manager focusing on battery-related technologies and co-creating new businesses. He spent twelve years in semiconductor product planning and customer support at Asahi Kasei Microdevices. He holds a master's degree in Electronic Engineering from Osaka University.

Ryoichi Takashima· Manager· Menlo Parkin

Manager focusing on IoT technology and new business creation. He previously worked as an ASIC designer at Asahi Kasei Microdevices, developing sensor devices. He graduated from Osaka University with a master's degree in science.

Takashi Morishita· General Manager· Menlo Parkin

General Manager of Asahi Kasei Corporate VC since 2008, with over 25 years of experience in open innovation and strategic alliances with high-tech startups in the US and Europe. He has been involved in more than 30 startup investments and led a portfolio company acquisition. He holds a PhD, MS, and BS in Chemical Engineering from the Tokyo Institute of Technology.

Takazumi Oshima· Manager· Menlo Park

Joined the CVC team in July 2025, in charge of investment strategy and execution. He previously worked in Corporate Strategy at Asahi Kasei Corporation on corporate FP&A and overseas planning, and spent 12 years at Robert Bosch in finance roles. He holds a bachelor's degree in Commerce from Waseda University and is a CPA.

Xinran Tao· Manager· Bostonin

Manager based in Boston focusing on healthcare investment. She previously worked at Asahi Kasei Pharma Corporation on the in vitro diagnostics business, in strategy, clinical trials, regulation, marketing, and medical affairs. She holds a master's degree in bioengineering from the Tokyo Institute of Technology.

Yoshiki Miyamoto· Manager· Tokyoin

Manager focusing on IIoT and Sustainability. He spent 10 years in R&D at Asahi Kasei E-materials and Asahi Kasei working on high-performance polymers. He holds a Master of Engineering degree from Osaka University.

Tharun Veeraiah· Manager· United Statesin

Tharun Veeraiah is an engineering intern at Daymaker and a general partner at Atland Ventures. He studies at the University of Minnesota, with interests in technology, philosophy, economics, and human beings.

Ohma Fujita· Vice President· San Mateo, California

Steven Berger· Consultant· Bostonin

Consultant with over 30 years of experience in innovation and entrepreneurship. He was part of Asahi Kasei America's CVC team from 2012 to 2022, was previously CEO of Crystal IS (acquired by Asahi Kasei in 2011), and held COO and CTO roles at FEI Company. He holds a PhD from Cambridge University.

What they invest in

from 46 of 59 portfolio companies

Healthtech ×16Biotech ×15AI & Machine Learning ×11Medical Devices ×11Deep Tech ×10Advanced Manufacturing ×9Cleantech ×9Digital Health ×7

HQs:United States×25Canada×5United Kingdom×2Japan×2Netherlands×2France×1

Who they back

founder profiles across 30 portfolio companies

63%

solo founders

19 of 30 mapped founding teams

37%

repeat founders

of 27 founders with career history

Founding team size:solo founder×192 founders×73 founders×24+ founders×2

Where their founders studiedfrom 24 founders with education data

Simon Fraser University ×3Delft University of Technology ×2Imperial College London ×2Northwestern University ×2Stanford University ×2

What their founders studiedfrom 25 founders with field-of-study data

Engineering ×14Chemistry ×3Medicine ×3Computer Science ×2

Where their founders worked beforefrom 27 founders with career history

McKinsey & Company ×2Rigimmune ×2

11 founders hold a PhD · 2 hold an MBA (of 27 with degree data)

Investments · 59 tracked

founders shown can be your intro path

By year:2024 · 1 2021 · 2 2018 · 2 2014 · 16 dated

Aerobiotixaerobiotix.com in 𝕏

A medical device company developing orthopedic and biological solutions.

BiotechCleantechHardwareHealthtechMedical DevicesOhio, US

David Kirschman(Surgeon Inventor)in

Co-investorsVivo Capital Horizon Technology Finance

AiCureaicure.com in 𝕏

AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Sabina Chadha(Chief Executive Officer)in Anand Ramaswamy(Chief Product Officer)in Jun Lu(VP of Engineering and AI)in

Co-investorsVIVE VC Accelmed Partners Palisades Growth Capital Tribeca Venture Partners Baird Capital New Leaf Venture Partners +3 more

Allievex Corpallievex.com

Develops novel therapies for rare pediatric neurodegenerative diseases.

Co-investorsLG Technology Ventures LifeSci Venture Partners Pappas Capital

AM Batteriesam-batteries.com

AM Batteries develops Powder to Electrode dry coating technology for lithium-ion electrode manufacturing, reducing solvent use and energy consumption compared to traditional slurry methods.

Advanced ManufacturingCleantechEnergyMassachusetts, US

Yan Wang(Director)in

Board Anil Achyuta(Director)in Jimmy Kan(Director)in Lisa Coca(Director)inLie Shi(Director)in

Co-investorsAnzu Partners Creative Ventures Foothill Ventures RA Capital SAIC Technologies Fund II, LLC TDK Ventures +3 more

Aryballearyballe.com in

Aryballe operates an ISO 7 cleanroom manufacturing facility for sensor production, enabling chemical functionalization and testing at scale with up to 1 million sensors per year capacity.

Advanced ManufacturingAI & Machine LearningDeep TechHardwareIoTGrenoble, FR

Co-investorsHCVC Innovacom Samsung Venture Investment Corporation SEB Alliance

Avation Medicalavation.com in 𝕏

Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.

Digital HealthHealthtechMedical DevicesValencia, US

Manish Vaishya, PhD(Chief Executive Officer, Co-Founder & Board Member)Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)

BoardThomas Shehab, MD(Director)

Co-investorsAngelini Ventures Arboretum Ventures Avestria Ventures ShangBay Capital LLC

Azafarosazafaros.com

Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.

BiotechDeep TechHealthtechMedical DevicesLeiden, NL

Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)

Co-investorsBioGeneration Ventures BioMedPartners Forbion Jeito Capital Pictet Group Seroba Life Sciences

Castorcastoredc.com inDefunct

Castor developed decision-support software that analyzed CAD files to help manufacturers decide between additive manufacturing and traditional production, offering cost and lead-time comparisons.

AI & Machine LearningCloud ComputingData & InfrastructureDigital HealthHealthtechMedical DevicesSaaSTel Aviv, IL

Derk Arts(Founder)in

Co-investorsF-Prime Capital Inkef Techstars Chartered Group Two Sigma Ventures

Circularisecircularise.com in 𝕏

Circularise provides supply chain traceability software that helps companies trace materials across complex value chains, connect data to products, and share verifiable information.

Circular EconomyLogistics & Supply ChainNew MaterialsSaaSDelft, NL

Mesbah Sabur(Co-Founder)inJordi de Vos(Co-Founder)in

Co-investors4impact capital Brightlands Venture Partners

Cyto-Factocytofacto.com

Cytofacto appears to be a Japanese startup involved in cell therapy / regenerative medicine, engaging in contract manufacturing of cell-based products (e.g. an agreement regarding manufacturing of "Stemchymal").

Advanced ManufacturingBiotechMedical Devices

Co-investorsKobe University Capital MPower

Everactiveeveractive.com

Everactive develops ultra-low power, self-powered systems-on-chip (SoCs) for Ambient IoT devices that sense, process, and wirelessly transmit data using harvested environmental energy instead of batteries.

HardwareIoTSemiconductorsSan Jose, US

Benton Calhoun(CEO and Co-Founder)inDavid Wentzloff(CTO and Co-Founder)inBrendan R Richardson(Executive Officer, Director)

BoardGeorge Kastendike(Director)Greg Papadopoulos(Director)inJack Busch(Director)

Co-investorsBlue Bear Capital Partners New Enterprise Associates (NEA)OUP (Osage University Partners)ABB Technology Ventures Fluke Venture Partners GE Ventures +1 more

Exactmerexactmer.com

Exactmer develops organic solvent-stable nanofiltration (OSN) membranes and a liquid-phase synthesis platform for pharmaceutical manufacturers, aimed at lower-cost and more scalable production of oligonucleotide and other advanced polymer therapeutics.

BiotechDeep TechNew MaterialsDagenham, GB

Feldan Therapeuticsfeldan.com in

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.

BiotechDeep TechMedical Devices

François-Thomas Michaud(Board Member & Chief Executive Officer)in

Co-investorsGenesys Capital Linearis Ventures Fonds de solidarité FTQ Zynext Ventures

Glycomineglycomine.com in 𝕏

Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.

BiotechSan Francisco, US

Agnes Rafalko(Executive Officer, Director)in Steven Axon(Chief Executive Officer)in Hicham Alaoui(Chief Scientific Officer)inRose Marino(Chief Medical Officer)in Peter McWilliams(Chief Business Officer)Geoffrey Hird(Chief Technology Officer)in

Co-investorsAdvent Life Sciences Chiesi Ventures CTI Life Sciences Fund L.P.Mission Bay Capital Mission Biocapital Remiges Ventures, Inc.+6 more

Hazel Technologies Inchazeltechnologies.com in 𝕏

Hazel Technologies develops shelf-life extension and modified atmosphere packaging solutions, including its BreatheWay membrane packaging platform, to maintain the quality of fruits and vegetables in the produce supply chain.

AgTechFoodTechNew MaterialsFresno, US

Patrick Flynn(Chief Marketing Officer)in Aidan Mouat(Chief Executive Officer, Director)in Parker R Booth(Chief Executive Officer, Director)in Adam Preslar(Chief Technology Officer)in

BoardTimothy Bluth(Director)Matthew Walker(Director)in

Co-investorsAliment Capital Climate Impact Capital Pangaea Ventures Us Inc.Pontifax AgTech Rhapsody Venture Partners S2G Investments +1 more

HistoWizhistowiz.com in 𝕏

HistoWiz provides digital pathology services including precision histology, immunostaining, slide archiving, and AI-powered image analysis for research and clinical laboratories.

AI & Machine LearningBiotechHealthtechMedical DevicesNew York City, US

Ke Cheng(Founder/CEO)inLinh Hoang(Chief Executive Officer)inJerry Kuang(Chief Operations Officer)Julie Feldstein(Chief Pathologist)in

Co-investorsvenBio Partners Vivo Capital Y Combinator Avlok Capital K5 Ventures MicroVentures

Impulse Spaceimpulsespace.com in 𝕏

Impulse Space develops in-space mobility infrastructure and spacecraft, enabling transportation and logistics between Earth orbit, the Moon, and Mars.

Deep TechDefense TechSpace TechRedondo Beach, US

Tom Mueller(Founder & CEO)inThomas Mueller(Founder)in Eric Romo(Executive Officer, Director)inMargaret Abernathy(Executive Officer)in

Board Michael Linse(Director)inJohn William Raymond(Director)

Co-investors137 Ventures Alumni Ventures Arctic Digital Balerion Space Ventures Banner VC Basecamp Fund +21 more

Ionomrionomr.com in 𝕏

Ionomr develops ion-exchange membrane and polymer materials for clean energy applications including fuel cells, hydrogen production, and energy storage.

CleantechDeep TechEnergyNew MaterialsVancouver, CA

Benjamin Britton, PhD.Bill Haberlin(CEO)in

Co-investorsFinindus NGIF Capital Pallasite Ventures SAIC Technologies Fund II, LLC Amazon Alexa Fund Chevron Technology Ventures +2 more

Kinskins.com in

Kins provides virtual and in-person physical therapy services delivered by licensed physical therapists, with specialty care for pelvic health, chronic illness, and gender-affirming care across multiple states.

Digital HealthHealthtechNew York, US

Co-investorsW Health Ventures Gp Llc

Koya AIgetkoya.ai in

Koya AI provides a data-as-a-service API for catalog data management, collecting, deduplicating, normalizing, categorizing, and enriching product data.

AI & Machine LearningData & InfrastructureE-commerceCambridge, US

Andre Mendes(Founder)in

Co-investorsBlank Ventures FJ Labs

LUCA Scienceluca-science.com

LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.

BiotechDeep TechHealthtechLongevity

Co-investorsFast Track Initiative Remiges Ventures, Inc.4BIO Capital Astellas Venture Management LLC Axil Capital DCI Partners Co. Ltd.

LumaCyte in

Early commercial stage company selling a real-time cell analyzer to pharma companies.

BiotechCharlottesville, US

Sean Hart(Executive Officer, Director)inRenee Hart(Executive Officer, Director)Robert Heiser(Director)Pete Buzy(Director)Dennis Walczewski(Director)Paul Meister(Director)

Co-investorsNovalis LifeSciences

Mangrove Lithiummangrovelithium.com in 𝕏

Mangrove Lithium is a cleantech company that develops a patented, feedstock-flexible electrochemical refining technology to convert diverse lithium feedstocks into battery-grade lithium hydroxide and carbonate.

CleantechEnergyNew MaterialsDelta, CA

Saad Dara(CEO & Co-Founder)in David St. Angelo(Chief Technology Officer)in Annie Liu(Chief Commercial and Strategy Officer)in

Co-investorsBMW i Ventures Breakthrough Energy Ventures BDC Capital Corporation Canada Growth Fund Orion Industrial Ventures ATEL Ventures +3 more

Moment Energymomentenergy.com in 𝕏

Moment Energy repurposes retired electric-vehicle batteries into second-life energy storage systems, sourcing used batteries from automakers like Nissan and Mercedes-Benz for off-grid and grid energy applications.

Circular EconomyCleantechEnergyHardwareSurrey, CA

Edward Chiang(Cofounder)in Sumreen Rattan(Cofounder)inGurmesh Sidhu(Cofounder)Gabriel Soares(Cofounder)in

Co-investorsVersion One Ventures Acario Innovation Collaborative Fund Expansion Venture Capital Fika Foresight +7 more

Multusmultus.bio in

Multus designs cell culture media for the industrial bioeconomy, applying AI, robotics, and biological expertise to media formulation.

AI & Machine LearningBiotechDeep TechFoodTechLondon, GB

Cai Linton(Founder)in

Co-investorsBig Idea Ventures Nourish Ventures SynBioVen Zero Carbon Capital Mandi Ventures Marinya Capital +1 more

Natural Fiber Welding, Inc.nfw.earth in 𝕏

NFW (Natural Fiber Welding) develops plant-based, plastic-free materials including a leather alternative (MIRUM), engineered textiles (CLARUS), footwear outsoles (PLIANT), and biobased foam (TUNERA) for use by fashion, footwear, and consumer brands.

Advanced ManufacturingCircular EconomyCleantechClimate TechNew MaterialsPeoria, US

Luke Haverhals(Founder and Chemist)inLuke Haverhals, Ph.D.(Founder)Steve Zika(Co-Founder, CEO)inRob Salter(CFO)inRobert E. Turner(Director)Rob Goldman(Executive Officer)

Co-investorsBMW i Ventures Collaborative Fund Community Development Venture Capital Alliance Ethos VC Evolution VC Partners Harvard Business Angels of Chicago +6 more

ORIori.co 𝕏

Radiant builds compute infrastructure and services designed to operate as a utility, providing the foundational platform for AI and intelligence applications at scale.

AI & Machine LearningCloud ComputingData & Infrastructure

Mahdi Yahya(President)inVishal Padiyar(Executive Chairman)

Co-investors6 Degrees Capital Artem Ventures Banyan Ventures Episode1 Humans Of The Internet Insiders Ventures +5 more

Path Roboticspath-robotics.com in 𝕏

Path Robotics develops AI-powered robotic welding systems that adapt in real-time to part variations, serving manufacturers in heavy industry, critical infrastructure, defense, and energy sectors.

Advanced ManufacturingAI & Machine LearningRoboticsColumbus, US

Andy Lonsberry(Founder & CEO)Alex Lonsberry(Founder)in

Board Nick Solaro(Director)in

Co-investorsCatapult Ventures Drive Capital Matter Venture Partners Presidio Ventures Taiwania Capital Xplorer Capital +8 more

PHARMAIN CORPORATIONpharmain.com inApr 2014

PharmaIN is a clinical-stage biopharmaceutical company developing peptide-based, subcutaneous self-injectable therapies through peptide engineering and drug delivery.

BiotechHealthtechBothell, US

Elijah Bolotin(Executive Officer, Director)

BoardJohn Presutti(Director)James Foght(Director)Lester Salans(Director)Tibor Papp(Director)

Plant Prefabplantprefab.com in 𝕏

Plant Prefab makes prefabricated buildings using a panel-based construction system that spans from open-cavity panels to finished modules, allowing custom solutions tailored to a project's design, site, and budget.

Advanced ManufacturingCleantechConstruction TechPropTechArvin, US

Steve Glenn(Founder)in

Board Michael Mann(Director)inRamin Kolahi(Director)

Co-investorsArba LLC ATEL Ventures Manta Ray Ventures Obvious Ventures

Power to Hydrogenpower-h2.com inJul 2024

Power to Hydrogen develops Anion Exchange Membrane (AEM) electrolyzer systems that convert water and AC power into high-pressure hydrogen for storage and hydrogen carriers like methanol and ammonia.

CleantechDeep TechEnergyHardwareColumbus, US

Paul Matter(Chief Executive Officer)Christopher Holt(Director)

BoardConstantine Karantaris(Director)Ryan Helon(Director)

Co-investorsAir Liquide Venture Capital (ALIAD)E8 Angels Finindus JERA MOL Switch Ventioneers Capital

Pulmocidepulmocide.com in

Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis.

BiotechHealthtech

Pete Strong(Co-founder)Garth Rapeport(Co-founder)inKazuhiro Ito(Co-founder)inJohn Murray(Co-founder)inDavid Mantusin

Co-investorsAdjuvant Capital Dementia Discovery Fund F-Prime Capital Jeito Capital Longwood Fund SR One Capital Management +4 more

Roundtriproundtriphealth.com in 𝕏

RoundTrip provides a platform for booking and coordinating non-emergency medical transportation, allowing care coordinators to arrange rideshare, medical sedans, wheelchair vans, stretcher vans, and ALS/BLS vehicles through a single workflow.

Digital HealthLogistics & Supply ChainMobility & Transportation

Co-investorsEarly Light Ventures Lighthouse Network Ventures Llc MEDA Angels Motley Fool Ventures

SetPoint Medicalsetpointmedical.com in 𝕏

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in

Board Blake Wu(Director)in Juan-Pablo Mas(Director)in

Co-investorsAlly Bridge Group New Enterprise Associates (NEA)Norwest Venture Partners Topspin Partners Catalio Capital Management, LP Citta Capital +7 more

Sight Machinesightmachine.com

Sight Machine develops AI agents that optimize manufacturing operations by analyzing industrial data, connecting production systems, and providing autonomous recommendations to improve output and reduce waste.

Advanced ManufacturingAI & Machine LearningEnterprise SoftwareSan Francisco, US

Jon Sobel(Chief Executive Officer and President)inNathan Oostendorp(Secretary and Treasurer)

Board Adrian Fortino(Director)inMark Jacobsen(Director)Roger Ehrenberg(Director)

Co-investorsDnx Ventures eLab Ventures FundersClub Future Energy Ventures Huron River Ventures Mercury Fund +5 more

Skippskipp.ai

Skipp is an AI-powered platform for home remodeling professionals that uses generative AI and generative design to redesign spaces with real products based on actual measurements and site conditions.

AI & Machine LearningConstruction TechPropTech

Co-investorsMetaProp The Fund

Solidblocksolidblock.co 𝕏

SolidBlock (DIBS) offers the TokenSuite platform for issuing, managing, and allocating asset-backed tokens on blockchain, with built-in KYC/AML whitelists, automated books and records, fund distribution, and financial due diligence.

Crypto & Web3FintechPropTech

Yael Tamar(Founder)in

Co-investorsBuiltUp Ventures Draper Associates MetroCap Partners

Swingswingtherapeutics.com in

Swing Therapeutics develops treatments for chronic pain conditions such as fibromyalgia, with clinical and research input from psychologists and pain management experts.

Digital HealthHealthtechMental Health

Mike Rosenbluth(Founder & CEO)in

Co-investorsAlumni Ventures JAZZ Venture Partners Metrodora Ventures Owl Ventures

Syngoisyngoi.comacquired by Artis BioSolutions

Artis BioSolutions is an integrated platform for genetic medicine that produces enzymatically synthesized synthetic DNA and develops it into clinical-grade advanced therapies with in-house GMP manufacturing.

Advanced ManufacturingBiotechMedical DevicesWatertown, US

Co-investorsBuenavista Equity Partners Columbus Venture Partners

Toolbxtoolbx.com in 𝕏

TOOLBX provides an e-commerce platform for building supply dealers and lumberyards, letting contractors and pro customers place online quotes and orders.

Construction TechE-commerceRetail TechSaaS

Erik Bornstein(Founder)in

Co-investorsAllied Venture Partners FJ Labs Flucas Ventures GroundBreak Ventures Operator Stack Overton Venture Capital +2 more

Trevi Systemstrevisystems.com in

Trevi Systems is a water technology developer that commercializes forward osmosis desalination, brine concentration, and energy recovery systems for seawater, brackish water, and industrial and municipal wastewater.

Petaluma, US

John Webley(Executive Officer, Director)inGary Carmignani(Executive Officer, Director)in

BoardLaird Cagan(Director)Donald Green(Director)Thomas Birdsall(Director)

UltraSenseultrasensesys.com 𝕏Nov 2018

UltraSense develops touch-sensing technology for automotive human-machine interfaces, fusing ultrasound, force, and capacitive sensing on a single chip to register intended touch through materials like metal, glass, wood, and leather.

HardwareIoTMobility & TransportationSemiconductorsSanta Clara, US

Mozafar Maghsoudnia(Executive Officer, Director)Mo Maghsoudnia(Founder)in

Co-investorsAbies Ventures Bosch Ventures GiTV, Inc.Robert Bosch Venture Capital Sony Ventures Corporation Artiman Ventures

UV Angeluvangel.com in 𝕏

UV Angel manufactures ultraviolet light-based air treatment systems that reduce bacteria, viruses, and fungi in occupied indoor spaces.

CleantechHardwareHealthtechIoT

Peter Kisluk(Chief Financial and Investment Officer)Dr. Linda Lee(Chief Medical Affairs & Science Officer)Nate Utz(Chief Revenue Officer)

Co-investorsMichigan Rise

Vital Connect inDec 2021

HealthtechCampbell, US

Nersi Nazari(Executive Officer, Director)inSteve Zadig(Executive Officer, Director)in

BoardRichard Feachem(Director)Tom Saunders(Director)

Co-investorsEssex Woodlands Healthcare Partners Revelation Partners Ally Bridge Group MVM Life Science Partners Trinity Capital

VitalConnectvitalconnect.com

VitalConnect develops wearable biosensor technology for remote and in-hospital patient monitoring, streaming up to 11 vital signs including live ECG to enable physicians to monitor patients recovering at home or in the hospital.

Digital HealthHealthtechMedical Devices

Co-investorsRevelation Partners Ally Bridge Group Trinity Capital

Zapticzaptic.com

Connected worker platform and no-code toolkit for frontline teams and operations.

Co-investorsBacked Molten Ventures

ZeroKeyzerokey.com in 𝕏Aug 2018

ZeroKey develops quantum-based real-time location system (RTLS) technology for indoor positioning, backed by over thirty patents.

Advanced ManufacturingAI & Machine LearningDeep TechIoTLogistics & Supply ChainCalgary, CA

Andrew Lowe(Executive Officer)Matthew Lowe(Executive Officer, Director)Hugh McMillan(Executive Officer, Director)

Co-investorsBrick Mortar Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Axine Water TechnologiesCurreioGT Medical TechnologiesIntegral Geometry ScienceiVexSolNoctrixRegeNephroRemallSimple HomesSuperTopsoundWealthPark

Exits · 1

1 acquisitions

Syngoiacq. by Artis BioSolutions

Portfolio news

latest coverage across their companies

Impulse Space raises $500M Series D, valued at $4.26B

Impulse Space · finance.yahoo.com · Jun 2, 2026

Moment Energy Raises US$40M+ in Series B Funding

Moment Energy · finsmes.com · May 5, 2026

Azafaros Raises $150M To Target Rare Neuro-Metabolic Diseases - BioSpace

Azafaros · biospace.com · May 13, 2025

Feldan Therapeutics Receives Investment from Zynext Ventures

Feldan Therapeutics · finsmes.com · Apr 17, 2025

Frequently asked questions

How many investments has Asahi Kasei Corporate Venture Capital made?: Asahi Kasei Corporate Venture Capital has 59 tracked investments, 1 of which have exited.
What stage does Asahi Kasei Corporate Venture Capital invest at?: Asahi Kasei Corporate Venture Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Asahi Kasei Corporate Venture Capital's typical check size?: Asahi Kasei Corporate Venture Capital typically writes checks of $200K – $5M.
What sectors does Asahi Kasei Corporate Venture Capital focus on?: Asahi Kasei Corporate Venture Capital focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Construction Tech, Digital Health, Energy, Hardware, Healthtech, IoT, Medical Devices, New Materials, PropTech, Robotics, Semiconductors.
Where is Asahi Kasei Corporate Venture Capital located?: Asahi Kasei Corporate Venture Capital is headquartered in Menlo Park, US.
Does Asahi Kasei Corporate Venture Capital lead rounds?: Yes, Asahi Kasei Corporate Venture Capital leads investment rounds.
Who does Asahi Kasei Corporate Venture Capital co-invest with?: Asahi Kasei Corporate Venture Capital most often shares deals with Vivo Capital, ATEL Ventures, Collaborative Fund, among 172 tracked co-investors.

Similar investors

Robert Bosch Venture Capital

Robert Bosch Venture Capital (Bosch Ventures) is the corporate venture capital arm of Robert Bosch, headquartered in Stuttgart, Germany, with offices across Europe, the US, Israel and China.

$1.6M – $27M

Global Startup Acceleration Program (JETRO GSAP)

The Global Startup Acceleration Program (GSAP) is a JETRO initiative, run with Japan's Cabinet Office and top overseas accelerators, that helps Japan-based startups pursue international business development through tailored, equity-free accelerator courses.

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

$100K – $10M

Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

$5K – $50M

Cowin Capital Group

Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.

$1.4M – $50M